About
Small Molecules to Target Parkinson's
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (12)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
By Phase
PHASE3: 2
By Status
WITHDRAWN: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT01762644Lead Sponsor
The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
PHASE3Withdrawn
Started: Aug 31, 2015 · Completed: Aug 31, 2016
NCT01762657Lead Sponsor
The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
PHASE3Withdrawn
Started: Sep 30, 2014 · Completed: Sep 30, 2015
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...